Switch theme
Sign up to access all valuation multiples
Global Bioenergies develops a process to convert renewable resources into hydrocarbons through fermentation.
2008
69
LTM Revenue $0.5M
LTM EBITDA -$12.2M
$20.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Global Bioenergies has a last 12-month revenue (LTM) of $0.5M and a last 12-month EBITDA of -$12.2M.
In the most recent fiscal year, Global Bioenergies achieved revenue of $0.4M and an EBITDA of -$4.8M.
Global Bioenergies expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Global Bioenergies valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $0.5M | XXX | $0.4M | XXX | XXX | XXX |
| Gross Profit | $0.5M | XXX | -$0.2M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | -59% | XXX | XXX | XXX |
| EBITDA | -$12.2M | XXX | -$4.8M | XXX | XXX | XXX |
| EBITDA Margin | -2570% | XXX | -1196% | XXX | XXX | XXX |
| EBIT | -$14.6M | XXX | -$6.8M | XXX | XXX | XXX |
| EBIT Margin | -3075% | XXX | -1689% | XXX | XXX | XXX |
| Net Profit | -$12.9M | XXX | -$6.6M | XXX | XXX | XXX |
| Net Margin | -2707% | XXX | -1625% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Global Bioenergies's stock price is EUR 1 (or $1).
Global Bioenergies has current market cap of EUR 17.2M (or $19.3M), and EV of EUR 18.0M (or $20.2M).
See Global Bioenergies trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $20.2M | $19.3M | XXX | XXX | XXX | XXX | $-0.76 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Global Bioenergies has market cap of $19.3M and EV of $20.2M.
Global Bioenergies's trades at 49.9x EV/Revenue multiple, and -4.2x EV/EBITDA.
Equity research analysts estimate Global Bioenergies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Global Bioenergies has a P/E ratio of -1.5x.
See valuation multiples for Global Bioenergies and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $19.3M | XXX | $19.3M | XXX | XXX | XXX |
| EV (current) | $20.2M | XXX | $20.2M | XXX | XXX | XXX |
| EV/Revenue | 42.5x | XXX | 49.9x | XXX | XXX | XXX |
| EV/EBITDA | -1.7x | XXX | -4.2x | XXX | XXX | XXX |
| EV/EBIT | -1.4x | XXX | -3.0x | XXX | XXX | XXX |
| EV/Gross Profit | 42.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | -1.5x | XXX | -2.9x | XXX | XXX | XXX |
| EV/FCF | -1.4x | XXX | -2.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialGlobal Bioenergies's last 12 month revenue growth is 41%
Global Bioenergies's revenue per employee in the last FY averaged $6K, while opex per employee averaged $0.1M for the same period.
Global Bioenergies's rule of 40 is -211% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Global Bioenergies's rule of X is -2466% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Global Bioenergies and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 41% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | -2570% | XXX | -1196% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -211% | XXX | -1155% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -2466% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $6K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 17% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 1630% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| TAQA | XXX | XXX | XXX | XXX | XXX | XXX |
| New Sources Energy | XXX | XXX | XXX | XXX | XXX | XXX |
| AGL Energy | XXX | XXX | XXX | XXX | XXX | XXX |
| APA Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Chrysos Corp. | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Global Bioenergies acquired XXX companies to date.
Last acquisition by Global Bioenergies was XXXXXXXX, XXXXX XXXXX XXXXXX . Global Bioenergies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Global Bioenergies founded? | Global Bioenergies was founded in 2008. |
| Where is Global Bioenergies headquartered? | Global Bioenergies is headquartered in France. |
| How many employees does Global Bioenergies have? | As of today, Global Bioenergies has 69 employees. |
| Is Global Bioenergies publicy listed? | Yes, Global Bioenergies is a public company listed on PAR. |
| What is the stock symbol of Global Bioenergies? | Global Bioenergies trades under ALGBE ticker. |
| When did Global Bioenergies go public? | Global Bioenergies went public in 2011. |
| Who are competitors of Global Bioenergies? | Similar companies to Global Bioenergies include e.g. TAQA, New Sources Energy, AGL Energy, APA Group. |
| What is the current market cap of Global Bioenergies? | Global Bioenergies's current market cap is $19.3M |
| What is the current revenue of Global Bioenergies? | Global Bioenergies's last 12 months revenue is $0.5M. |
| What is the current revenue growth of Global Bioenergies? | Global Bioenergies revenue growth (NTM/LTM) is 41%. |
| What is the current EV/Revenue multiple of Global Bioenergies? | Current revenue multiple of Global Bioenergies is 42.5x. |
| Is Global Bioenergies profitable? | Yes, Global Bioenergies is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Global Bioenergies? | Global Bioenergies's last 12 months EBITDA is -$12.2M. |
| What is Global Bioenergies's EBITDA margin? | Global Bioenergies's last 12 months EBITDA margin is -2570%. |
| What is the current EV/EBITDA multiple of Global Bioenergies? | Current EBITDA multiple of Global Bioenergies is -1.7x. |
| What is the current FCF of Global Bioenergies? | Global Bioenergies's last 12 months FCF is -$14.9M. |
| What is Global Bioenergies's FCF margin? | Global Bioenergies's last 12 months FCF margin is -3121%. |
| What is the current EV/FCF multiple of Global Bioenergies? | Current FCF multiple of Global Bioenergies is -1.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
